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Available online 29 February 2008Dietary fructose has been suspected to contribute to development of metabolic syndrome. However,
underlying mechanisms of fructose effects are not well characterized. We investigated metabolic outcomes
and hepatic expression of key regulatory genes upon fructose feeding under well deﬁned conditions. Rats
were fed a 63% (w/w) glucose or fructose diet for 4 h/day for 2 weeks, and were killed after feeding or 24-hour
fasting. Liver glycogenwas higher in the fructose-fed rats, indicating robust conversion of fructose to glycogen
through gluconeogenesis despite simultaneous induction of genes for de novo lipogenesis and increased liver
triglycerides. Fructose feeding increased mRNA of previously unidentiﬁed genes involved in macronutrient
metabolism including fructokinase, aldolase B, phosphofructokinase-1, fructose-1,6-bisphosphatase and
carbohydrate response element binding protein (ChREBP). Activity of glucose-6-phosphate dehydrogenase, a
key enzyme for ChREBP activation, remained elevated in both fed and fasted fructose groups. In the fasted
liver, the fructose group showed lower non-esteriﬁed fatty acids, triglycerides and microsomal triglyceride
transfer protein mRNA, suggesting low VLDL synthesis even though plasma VLDL triglycerides were higher. In
conclusion, fructose feeding induced a broader range of genes than previously identiﬁed with simultaneous
increase in glycogen and triglycerides in liver. The induction may be in part mediated by ChREBP.
© 2008 Elsevier B.V. All rights reserved.Keywords:
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Amoderate amount of fructose from fresh fruits and vegetables has
long been a component of human diets. However, abundant produc-
tion of reﬁned sweeteners has dramatically increased fructose intake.
An estimated average consumption of added sugars (reﬁned cane and
beet sugar, corn sweeteners, edible syrups, and honey) in the United
States is 126 g/capita/day in 2000based on food supplydata [1]. Popkin
and Nielsen also estimated that more than 30% of carbohydrates
consumed came from added sugars in the United States [2].217 265 0925.
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l rights reserved.In humans, high fructose in diets reduces insulin sensitivity [3] and
elevates plasma triglycerides in both fed and fasting conditions [4]. In
animals, diets high in fructose cause multiple symptoms of metabolic
syndrome such as insulin resistance [5–7], impaired glucose tolerance
[8], hyperinsulinemia [9], hypertension [9], and hypertriglyceridemia
[7,8]. Thus, high consumption of dietary fructose, primarily from sucrose
and high-fructose corn syrup, has been implicated as a contributing
factor to the development of obesity and accompanying metabolic
abnormalities such as insulin resistance and hypertriglyceridemia.
Metabolism of dietary fructose, which occurs mainly in liver,
differs from that of glucose. Hepatic glucose metabolism is acutely
regulated by phosphofructokinase I (PFK I), a key regulatory step of
glycolysis. In contrast, fructose enters the glycolytic pathway at the
triose level, bypassing PFK I. This difference in initial metabolism of
fructose not only acutely affects carbohydrate metabolism by chan-
ging supply of intermediate metabolites, but also induces metabolic
adaptation including changes in gene expression. Previous studies
reported increasedmRNA expression of glycolytic (liver-type pyruvate
kinase, PK) [10], lipogenic (fatty acid synthase, FAS) [11], and
gluconeogenic enzymes (glucose-6-phosphatase, G6Pase; phosphoe-
nolpyruvate carboxykinase, PEPCK) [12,13].
However, several confounding factors must be resolved to deﬁne
the differential effect between fructose and glucose on gene expression
Table 1
Primer sequences used for real-time PCR
Gene Genbank
KHK Sense ACGGATCGCAGGTGCCTAT NM031855
Antisense AGCACAGTGCAGGAGTTGGA
AldolaseB Sense GCCACCTCACACAGCTTCTG NM012496
Antisense TCGGTGAGCCATGATGACA
GK Sense TGTGAGGCACGAAGACCTAGAC NM012565
Antisense TCCTACGATGTTGTTCCCTTCTG
GKRP Sense AAACGATATCAGCATGTGATCGA NM013120
Antisense GCCGCTTCATACCCTGACA
PFKI Sense CCATGGATGAGAAGAGGTTTGAC BC061791
Antisense GGTGGGCGAGGAGCTTGTA
PK Sense GGGTGTGAACTTGCCAAACA NM012624
Antisense CCGAAGCGCAGATCCAAA
G6Pase Sense TTCCCATCTGGTTCCACATTC NM013098
Antisense CGAGGTTGAACCAGTCTCCAA
FAS Sense TCGGCGAGTCTATGCCACTATT NM017332
Antisense ACAGAGAACGGATGAGTTGTTCCT
GPAT Sense GACGAAGCCTTCCGAAGGA AF021348
Antisense GACTTGCTGGCGGTGAAGAG
CPT1a Sense GGCTCTGGGTGGCAGTCAT NM031559
Antisense CCGTGTTCTGCAAACATCCA
HMGCoAS Sense ACCCTCGATGACGTGCAATAT NM173094
Antisense AGCCGAGCTAGGGATTTCTG
AOX Sense AAGAACTCCAGATAATTGGCACCTA NM017340
Antisense TTTCCAAGCCTCGAAGATGAG
SREBP1c Sense CGACGGAGCCATGGATTG L16995
Antisense CAAATAGGCCAGGGAAGTCACT
ChREBP Sense CAGATGCGGGACATGTTTGA AB074517
Antisense AATAAAGGTCGGATGAGGATGCT
Mlx Sense CCGCAGACTCTACGGGAGATT NM001034112
Antisense TGGCTGCTCTTCGGGTTTC
G6PD Sense TTCCGGGATGGCCTTCTAC NM017006
Antisense TTTGCGGATGTCATCCACTGT
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metabolism are strongly regulated by hormones such as insulin,
glucagon and glucocorticoids, and are sensitive to nutritional status
[14]. Many previous studies were conducted without clearly deﬁning
fed and fasted conditions [15,16]. Second, existing studies typically
investigated the effect of fructose on expression of only one or two
genes at a time, thus were unclear in the scope of the fructose effect
[10,12,13]. Third, previous studies vary widely in the ratio of fructose
and other carbohydrate sources in diets [15,17]. A small amount of
fructose in the presence of high levels of glucose increased the net
hepatic glucose uptake and the glycogen synthesis [18–20]. It is un-
known whether or not fructose alone can increase glycogen synthesis
in the absence of concomitant administration of glucose. Also, there is
likely a difference between acute and chronic effects of fructose ad-
ministration because a temporary decrease in food intakewas reported
when a diet is switched from high glucose to high fructose [21].
Another question yet to be addressed is the underlying mechanism
that mediates fructose effects on gene expression. Carbohydrate re-
sponse element binding protein (ChREBP), a transcription factor of the
bHLHLZ family, induces lipogenic genes such as PK [22], S14 [23],
acetyl-CoA carboxylase (ACC) [24] and FAS [25] in response to high
glucose. However, a recent study showed that ChREBP-null mice were
intolerant to high sucrose/fructose diet, suggesting a critical role of
ChREBP in fructose metabolism [26].
Therefore, the objectives of the present study were to investigate 1)
the differential effect of dietary fructose and glucose on gene expression
and on carbohydrate and lipid metabolism in well deﬁned conditions,
and 2) a possible role of ChREBP in the process. We achieved this
objective by analyzing key regulatory genes and metabolic outcome in
clearly deﬁned metabolic conditions: 1) in both fasted and fed states,
2) after adapting to a diet for 2weeks, and3) using a fructose-only diet to
exclude potential confounding effects of fructose on the dietary glucose
metabolism.
2. Materials and methods
2.1. Animals and diets
Twenty-four Sprague–Dawley male rats (5 weeks old, Harlan, Indianapolis, IN)
were acclimated for 2 days and adapted to a 4 h/day feeding protocol for 1 week with a
standard laboratory diet. This meal feeding regimen synchronizes metabolic conditions
of animals, and has been used to study regulation of metabolism by nutrients [27,28].
The animals were individually housed with controlled temperature and lighting (22±
2 °C and a 12-hour light/dark cycle). After adaptation, the rats were fed with either a
glucose (n=12) or a fructose (n=12) pelleted diet for 2weeks. Glucose and fructose diets
(Dyets Inc., Bethlehem, PA) were formulated by replacing the carbohydrate source in
AIN-93G diet with glucose (anhydrous dextrose) and fructose, respectively. Food
consumption was measured every day for each rat. After 2 weeks, half of each group
(n=6) was fasted for 24 h before euthanizing. The other half of the animals were killed
at the end of a 4 h-feeding. All procedures under protocol were reviewed and approved
by the University of Illinois Laboratory Animal Care Advisory Committee.
2.2. Blood glucose analysis
Blood was collected from the saphenous vein of conscious rats using micro-
hematocrit tubes. Blood glucose was measured using One Touch BASIC Diabetes Moni-
toring System (Lifescan Inc., Milpitas, CA).
2.3. Processing and analysis of blood
After blood sampling for glucose analysis, rats were anesthetized by intraperitoneal
injection of sodium pentobarbital (50 mg/ml). The abdomen was opened, and ∼6 ml
blood was drawn from vena cava in a syringe containing 120 μl of 50 mM EDTA (ﬁnal
1 mM). After centrifugation, plasma was stored at −80 °C. Plasma insulin and glucagon
were measured using commercial radioimmunoassay kits (Linco Research, St. Charles,
MO). Concentration of plasma non-esteriﬁed fatty acids (NEFA) was measured using a
commercial kit (Wako, Richmond, VA).
The concentration and distribution of triglycerides among the very low-density
lipoprotein (VLDL), low-density lipoprotein (LDL), and high-density lipoprotein (HDL)
fractions in plasma were measured by use of a modiﬁed lipoprotein cholesterol auto-
proﬁler method [29]. This method involves 1) rapid separation of VLDL, LDL and HDL
particles by short-spin density gradient ultracentrifugation in a rotor with swingout
buckets (Beckman SW 50.1, Beckman Coulter Inc., Fullerton, CA); 2) continuous onlinemixing of the efﬂuent from density gradient tubes with enzymatic triglyceride assay
reagent (Roche Diagnostics, Indianapolis, IN); 3) online incubation and continuous ﬂow
measurement of absorbance; and 4) computerized calculation of triglycerides
associated with VLDL, LDL and HDL peaks.
2.4. Histochemistry
The liver was removed and weighed. For histochemical evaluation of glycogen in
the liver, one ∼5 mm thick slice from the left lateral lobe, right medial lobe and caudal
lobe of the liver were immersion ﬁxed in absolute ethanol for 24 h, then processed
through graded alcohols and imbedded in parafﬁn. Sections 3 μm thick were stained
with periodic acid Schiff (PAS) reagent for visual examination under the microscope.
2.5. Determination of liver glycogen content
Liver glycogen content was measured by a phenol–sulfuric acid colorimetric assay
as described previously [30]. Brieﬂy, powdered frozen liver samples were dissolved in
30% (wt/vol) KOH saturated with Na2SO4 and then boiled for 15 min to get a
homogenous solution. Then samples were cooled on ice for 30 min, and 95% ethanol
was added to precipitate glycogen. After centrifuging at 840 ×g, glycogen pellets were
resuspended in distilled water. Samples were incubated in the 5% phenol solution and
96% sulfuric acid solution at room temperature for 10 min, and the absorbance was read
at 490 nm.
2.6. Fatty acid analysis
Gas chromatography was used to quantify total concentration of triglyceride and
NEFA in the liver. The detailed procedure has been reported previously [28]. Brieﬂy,
total liver lipids were extracted using chloroform/methanol (2:1, vol:vol) that contained
50 μg each of C17:0, free fatty acid and triglyceride as internal standards. The lipid
extract was then separated by thin layer chromatography into free fatty acids and
triglycerides. Each fatty acid fraction was methylated using Methanolic HCl (Supelco,
Bellefonte, PA). The amount of individual fatty acid was determined by comparing gas
chromatography peaks with a peak of internal standard (17:0).
2.7. RNA analysis
Remaining liverwas frozen immediately in liquid nitrogen and subsequently stored at
−80 °C. Total RNA from liver tissue was extracted by TRIzol reagent (Invitrogen, Carlsbad,
CA) according to the manufacturer's instructions. RNA quality and concentration were
determined by agarose gel electrophoresis and spectrophotometry, respectively. RNA
expression of target genes was measured using a real-time quantitative PCR method with
Table 2
Weight gain and liver characteristics
Glucose Fructose
Fed Fasted Fed Fasted
Weight gain (g) 102±27 91±41
Liver weight (g) 9.1±1.2ab 6.7±0.5c 10.0±1.1a 8.2±1.8bc
Relative liver weight (%)
(liver weight/body weight)
3.5±0.3b 2.6±0.4c 4.2±0.5a 3.3±0.8b
Glycogen (mg/g liver) 13.2±5.2b 0.7±0.5c 22.8±7.0a 1.0±0.5c
Triglyceride (μmol/g liver) 5.1±0.7c 11.7±1.2a 9.2±2.1b 5.3±0.6c
Non-esteriﬁed fatty acids (nmol/g liver) 139±51b 304±96a 156±45b 172±60b
Animals were fed either the glucose diet or the fructose diet for 2 weeks. Half of
the animals were killed at the end of 4 h-feeding, and the other half were killed
after fasting for 24 h. Liver glycogen content was measured by a phenol–sulfuric
acid colorimetric assay. Liver triglycerides and non-esteriﬁed fatty acids weremeasured
by gas chromatography. Values are expressed as the means±standard deviation (n=6).
The different superscripts denote statistical difference (pb0.05).
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[30]. Brieﬂy, 2 μg puriﬁed RNA was reverse transcribed into complementary DNA. Pub-
lished primer sequences were used for phosphoenolpyruvate carboxykinase (PEPCK),
fructose-1,6-bisphosphatase (FBPase) [31], microsomal triglyceride transfer protein (MTP)
[32], and fatty acid translocase/CD36 (FAT/CD36) [33]. Primers for other genes were
designed using the Primer Express software (Applied Biosystems) and listed in Table 1. All
primers were purchased from MWG Biotech (High Point, NC). Real-time PCR was
performed using an ABI Prism 7700 sequence detection system (Applied Biosystems).
Ampliﬁcation efﬁciency of each primer setwas veriﬁed before sample analysis. ThemRNA
abundance relative to 18 S rRNA was determined using comparative critical threshold
method according to manufacturer's instruction.
2.8. Assay of hepatic glucose 6 phosphate dehydrogenase (G6PD) enzyme activity
About 0.5 g of liver was homogenized in 5 ml of a 0.25 M sucrose solution con-
taining 1 mM of EDTA in 10 mM of Tris–HCl buffer (pH 7.6). After precipitating a nuclei
fraction by centrifuging at 2450 ×g for 10 min, the supernatant was centrifuged at
105,000 ×g for 60 min at 4 °C to obtain a cytosolic fraction. Protein concentration was
determined by the BCA protein assay kit (Pierce, Rockford, IL) with bovine serum
albumin as a standard. The enzyme activities of G6PD (EC1.1.1.49) in supernatant were
determined with a method described by Dror [34]. The reaction solution contained
0.16 M of Tris–HCl buffer (pH 7.6), 30 mM of MgCl2, 3.3 mM of glucose-6-phosphate,
1.6mM of oxidized NADP+, and 0.5 U of type VI 6-phosphogluconate dehydrogenase/ml.
Reactionwas started by adding 6-phosphogluconate dehydrogenase, and appearance of
NADPH was measured with a spectrophotometer at 340 nm.
2.9. Data analysis and statistics
Data were analyzed by one-way ANOVA coupled with Fisher's post-hoc test using
Statview 5.0.1 (SAS Institute, Cary, NC). All data are reported as means±standard de-
viation (SD). Signiﬁcance was set at pb0.05.
3. Results
3.1. Food intake and growth
As shown in Fig. 1, the fructose group ate 32% less food than the
glucose group in the ﬁrst day of switching diets from a high-starch
laboratory diet. On the second day, however, the food intake of the
fructose group increased to the level of the glucose group, indicating
that the rats were able to adapt to the high-fructose diet in 1 day. The
ﬁnal weight gain of the two groups for the two-week period did not
reach a signiﬁcant difference (Table 2), showing that the high-fructose
diet was well tolerated. The relative liver weights (liver weight (g)/
body weight (g)) of the fructose groups were signiﬁcantly higher than
those of the glucose groups, indicating hepatomegaly as a response to
a high-fructose diet (Table 2).Fig. 1. Food intake of fructose-fed animals was lower in the ﬁrst day. Animals were fed
either a glucose diet (diamond) or a fructose diet (triangle) for 2 weeks, and food intake
was measured daily. Values are means, and error bars denote standard deviation. For
each time point, n=12 for each group. ⁎signiﬁcantly different (pb0.05).3.2. Liver and plasma metabolic proﬁles
Liver sliceswere stained by the periodic acid Schiff (PAS)method to
evaluate the magnitude and distribution of hepatic glycogen storage.
Compared with the glucose-fed group, the fructose-fed group showed
more intense staining, primarily in the periportal region (Fig. 2).
Quantitation of liver glycogen was consistent with this histological
observation, being 1.7 times higher in the fructose-fed animals than in
the glucose-fed animals (Table 2). This increased glycogen deposition
indicates a robust conversion of fructose to glucose-6-phosphate, and a
larger metabolic role of liver in disposing dietary carbohydrate in the
fructose group than in the glucose group, inwhich skeletal muscle andFig. 2. Glycogen store was increased in the periportal area of fructose-fed animals.
Animals were fed either a glucose diet or a fructose diet for 2 weeks, and were
euthanized at the end of a 4 h-feeding. Liver glycogen was stained by periodic acid
Schiff. A, liver from the glucose-fed animals; B, fructose-fed animals; PP, periportal area;
CV, central venous area.
Table 3
Blood glucose and plasma triglycerides, non-esteriﬁed fatty acids, insulin, and glucagon
concentrations
Glucose Fructose
Fed Fasted Fed Fasted
TG (mg/dl plasma) 68±17b 25±3c 132±56a 34±12c
VLDL 52.2±12.8b 6.8±0.9d 101.7±42.9a 14.6±5.1c
LDL 4.3±1.1b,c 3.7±0.5c 16.6±2.2a 6.3±2.2b
HDL 11.1±2.6ab 14.2±1.9a 8.8±1.1b 13.4±4.7a
NEFA (mEq/L plasma) 0.04±0.04a 0.27±0.09b 0.12±0.13a 0.22±0.05b
Glucose (mg/dl whole blood) 84±14a 45±10c 63±12b 50±9b,c
Insulin (ng/ml plasma) 5.6±1.7b 1.1±1.0c 9.4±3.6a 1.3±1.0c
Glucagon (pg/ml plasma) 90±27a,b 64±30b,c 120±54a 47±14c
Insulin/glucagon ratio 77±39a 28±32b 91±19a 35±33b
Animals were treated as described in Table 2. At the end of 2 weeks, blood was
drawn from conscious rats for blood glucose determination. Plasma was prepared
from the blood collected via cardiac puncture after anesthesia, and was used for
all other analyses. Values are expressed as the means±standard deviation (n=6).
The different superscripts denote statistical difference (pb0.05).
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fasted condition, both histology and quantitation showed depletion of
glycogen in both glucose and fructose groups (Table 2, histology data
not shown).
The glucose groups showed lower liver triglycerides in a fed state
than in a fasted state (Table 2), a consistent observation by others [35],
whereas the fructose groups showed a reversed pattern (Table 2). The
hepatic triglyceride concentration was higher in the fructose group
than in the glucose group in the fed condition, suggesting increased
fatty acid and triglyceride synthesis by liver in the fructose group in
the fed state. In contrast, both triglycerides and NEFA were signi-
ﬁcantly lower in the fructose group than in the glucose group when
animals were fasted, suggesting decreased uptake and/or increased
utilization of fatty acids in the liver of the fructose group in the fasted
condition (Table 2).Fig. 3. Regulation of hepatic genes involved in carbohydrate and lipid metabolism by dietary
animals were killed at the end of 4 h-feeding, and the other half were killed after fasting for 2
The data were expressed as a relative change from the glucose-fed group. Glucose-fed gro
fructose-fasted group, dark gray bar. Results are expressed as means, and error bars show
difference (pb0.05). A, Fructose metabolism: ketohexokinase (KHK), aldolase B. B, Glycolysis:
pyruvate kinase (PK). C, Gluconeogenesis: phosphoenolpyruvate carboxykinase (PEPCK), fruc
fatty acid synthase (FAS), glycerol-3-phosphate acyltransferase (GPAT), and microsomal trigl
(FAT/CD36), carnitine palmitoyltransferase 1a (CPT1a), mitochondrial 3-hydroxy-3-methyl
factors: sterol regulatory element binding protein 1c (SREBP1c), carbohydrate regulatory prTable 3 shows that blood glucose concentrations from conscious
animals were lower in the fructose group than in the glucose group in
the fed condition, whereas there was no difference in blood glucose
levels between fasted groups. On the other hand, the plasma insulin
was signiﬁcantly higher in the fructose group than in the glucose
group in the fed condition. Plasma glucagon did not reach statistical
signiﬁcance between the fructose and glucose groups (Table 3).
However, the fructose group showed much higher glucagon in the fed
state than in the fasted state (2.6×, pb0.05), whereas the glucose
group showed a smaller change (1.4×, nonsigniﬁcant) (Table 3). Our
previous study also showed an increase in glucagon after feeding a
moderately-high protein diet [36], suggesting glucagon may play a
role in inducing gluconeogenic genes when a diet contains high
fructose or high protein. Plasma VLDL and LDL triglycerides were
higher in the fructose group in both fed and fasted conditions, where-
as no difference was observed in plasma NEFA between the fructose
and glucose groups (Table 3).
3.3. Gene regulation by dietary fructose
Compared with the glucose-fed group, the fructose-fed group had
higher mRNA of fructose metabolizing enzymes, ketohexokinase
(KHK, fructokinase) and aldolase B (Fig. 3 A). Fig. 3 B shows genes
for the glycolysis pathway. Phosphofructokinase I (PFK I) and PK
mRNA were induced more in the fructose-fed group than in the
glucose-fed group, whereas there was no difference in the mRNA
expression of glucokinase (GK) and glucokinase regulatory protein
(GKRP) between the fructose and glucose groups. There was no
difference in the glycogen synthase RNA among 4 groups (data not
shown). However, glycogen synthase is acutely activated by insulin.
Thus, the increased glycogen deposition (Table 2) and plasma insulin
(Table 3) in the fructose-fed group suggest a higher glycogen synthase
activity in the fructose-fed group than in the glucose-fed animals.
Among the gluconeogenic genes, the fructose-fed group had higherfructose. Animals were fed either a glucose diet or a fructose diet for 2 weeks. Half of the
4 h. RNA abundance related to ribosomal 18 S RNAwas determined using real-time PCR.
up, white bar; glucose-fasted group, black bar; fructose-fed group, light gray bar; and
standard deviation from ﬁve to six animals. Different superscript denotes statistical
glucokinase (GK), glucokinase regulatory protein (GKRP), phosphofructokinase I (PFK I),
tose-1,6-bisphosphatase (FBPase) and glucose-6-phosphatase (G6Pase). D, Lipogenesis:
yceride transfer protein (MTP). E, Fatty acid transporter/oxidation: fatty acid translocase
glutaryl (HMG) CoA synthase (HMGCS), and acyl-CoA oxidase (AOX). F, Transcription
otein (ChREBP), and Max-like factor X (Mlx).
345H.-Y. Koo et al. / Biochimica et Biophysica Acta 1782 (2008) 341–348mRNA expressions of FBPase and G6Pase than the glucose-fed group,
but not PEPCK mRNA (Fig. 3 C).
Fig. 3 D shows genes involved with the lipogenesis pathway.
Compared to the glucose-fed group, the fructose-fed group had
signiﬁcantly higher mRNA expressions of FAS, a key lipogenic enzyme,
and glycerol-3-phosphate acyltransferase (GPAT), a regulatory
enzyme of glycerolipid synthesis. Interestingly, mRNA of MTP, a tran-
sporter that has a regulatory role in VLDL synthesis, was signiﬁcantly
lower in the fructose group in fasted condition (Fig. 3 D) although
plasma VLDL was higher (Table 3). There was no signiﬁcant difference
in the gene expression of fatty acid oxidation enzymes between the
glucose-fasted and fructose-fasted animals (Fig. 3 E).
Among transcription factors, ChREBP mRNA was signiﬁcantly
induced by fructose feeding, whereas sterol regulatory element bind-
ing proteins-1c (SREBP1c) gene did not reach statistical signiﬁcance
(p=0.06) although the magnitude of induction by fructose was similar
to ChREBP (Fig. 3 F). The fructose diet did not affect the expression of
Max-like factor X (Mlx), the heterodimeric partner of ChREBP (Fig. 3 F).
3.4. Enzyme activity and mRNA expression of glucose-6-phosphate
dehydrogenase (G6PD)
We measured mRNA and activity of G6PD, the regulatory enzyme
of the pentose phosphate pathway, in the liver to determinewhether a
fructose effect on G6PDwas at the gene expression level (Fig. 4). G6PD
activity was higher in the fructose group than in the glucose group in
both fed and fasted conditions (Fig. 4 A). In contrast, there were large
variations in mRNA expression within each group, and no signiﬁcant
difference was observed among groups (Fig. 4 B). Neither was thereFig. 4. Enzyme activity of glucose-6-phosphate dehydrogenase (G6PD) was induced in
the fructose groups, whereas mRNA expression of G6PD did not differ among groups.
Animals were fed either the glucose diet or the fructose diet for 2 weeks. Half of the
animals were killed at the end of 4 h-feeding, and the other half were killed after fasting
for 24 h. A, cytosolic fraction was used for enzymatic assay. G6PD activity was
determined bymeasuring NADP+ reduction. B, RNA abundance related to ribosomal 18S
RNA was determined using real-time PCR. Results are expressed as means, and error
bars show standard deviation (n=6). Different superscript denotes statistical difference
(pb0.05). GFD, glucose-fed group; GFS, glucose-fasted group; FFD, fructose-fed group;
FFS, fructose-fasted group.correlation between the mRNA expression and the enzyme activity of
G6PD (r2=0.0146), indicating that the induction of G6PD by dietary
fructose is at the translational or post-translational level. Moreover,
the lack of effects of fasting and feeding on the G6PD activity (Fig. 4 A)
suggest a slow turnover rate of the enzyme.
4. Discussion
4.1. A unique pattern of gene expression by fructose feeding
The liver plays the major role in fructose metabolism. The current
study provided a well deﬁned view of fructose effects on metabolic
outcome and the expression of genes involved in the metabolic
pathways of fructose. As summarized in Fig. 5 A, dietary fructose in the
fed state induces a broader range of hepatic genes involved in the
pathways for fructose metabolism than previously identiﬁed.
KHK and Aldolase B are required speciﬁcally for fructosemetabolism
in liver before fructose metabolites enter the glycolysis/gluconeogenic
pathways. Studies reported that aldolaseBmRNAwas inducedby insulin
and dexamethasone, and repressed by glucagon in rat hepatocytes
[37,38]. However, our study showed that fasting and refeeding had only
small and nonsigniﬁcant effects on KHK and aldolase B gene expression
in the glucose group, whereas these genes were signiﬁcantly induced in
the fructose-fed group (Fig. 3 A). The underlying mechanism of this
fructose effect is yet to be elucidated. Although fructose does not sti-
mulate insulin secretion, chronic fructose feeding causes insulin resis-
tance, resulting in higher plasma insulin [21]. Thus, increased plasma
insulin in the fructose-fed group (Table 3) may have contributed to the
induction of KHK and aldolase B genes. However, presence of an un-
identiﬁed insulin independent mechanism cannot be ruled out.
Among genes of key regulatory enzymes of gluconeogenesis, mRNA
of FBPase andG6Pasewere induced by dietary fructose (Fig. 3 C, Fig. 5 A).
The induction of FBPase mRNA by fructose (Fig. 3 C) is particularly
interesting because the FBPase expression was unaffected by feeding
cycles [39] (Fig. 3C, glucose groups). When fed with glucose, dietary
fructose has been shown to stimulate glycogen synthesis from glucose
[18–20]. However, because no dietary glucose was present in our
fructose diet, the substrate for glycogen synthesis in the fructose-fed
group likely came from dietary fructose through the gluconeogenic
pathway. Thus, the induction of FBPase is consistent with the robust
accumulationof glycogen in the fructose-fed animals in this study (Fig. 2,
Table 2).
Contrary to the response of G6Pase and FBPase, the expression of
PEPCK, another key enzyme of gluconeogenesis, was not increased by
the fructose diet either in fasting or in fed condition compared with
the glucose group (Fig. 3 C). Unlike G6Pase and FBPase, PEPCK enzyme
has no known acute regulation, and is primarily regulated at tran-
scriptional level [40]. Because simultaneous induction of PK and
PEPCK could result in a futile cycle, the lack of PEPCK induction by
fructose is physiologically suitable when PK was highly induced by
fructose in this study (Fig. 5).
It is noteworthy that fructose showed a differential effect on PEPCK
and G6Pase genes in our study (Fig. 3 C) because these two genes
largely share common transcriptional regulatory mechanisms. Both
genes are induced by glucagon acting via cAMP [41] and glucocorti-
coids [42,43], and repressed by insulin [44]. Both genes require in-
teraction of peroxisome proliferator-activated receptor γ coactivator
1α (PGC-1α) with hepatocyte nuclear factor 4α [45]. Massillon et al.
showed that xylitol infusion stimulated G6Pase transcription, whereas
it decreased PEPCK expression and suggested an involvement of the
pentose phosphate pathway in the differential regulation of G6Pase
and PEPCK [46]. Consistent with their ﬁndings, our study showed that
the fructose diet increased G6PD activity, a rate-limiting enzyme of
the pentose phosphate pathway (Fig. 4). Further studies will be
warranted to elucidate the underlying mechanism of the differential
effects of dietary fructose on G6Pase and PEPCK.
Fig. 5. Summary of changes in gene expression and metabolic outcomes by dietary fructose. A, fed, and B, fasted animals. Numbers represent relative changes of the fructose group
from the glucose group. Bold letters denote statistically signiﬁcant (pb0.05).
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the glycolysis pathway (Fig. 5), was about two times higher in the
fructose-fed group than in the glucose-fed group (Fig. 3 B). This pa-
radoxical induction of both PFK I and FBPase genes by fructose was
also reported in the small intestine of neonatal rats [47]. Because PFK I
is under strong regulation by an allosteric activator fructose-2,6-
bisphosphate [48], it is yet to be elucidated whether this simultaneous
induction of PFK I and FBPase genes actually increases enzyme acti-
vities, and thus results in futile cycling (Fig. 5). Alternatively, upre-
gulation of FBPase and PFK I genes may be zone speciﬁc, expressed
primarily in the periportal area and in the perivenous area in liver,
respectively, as reported by Jungermann [49].
4.2. A possible role of ChREBP in mediating the fructose effects
ChREBP induces lipogenic genes such as PK [50], ACC [24], FAS [51]
and possibly GPAT [52] in response to high carbohydrate (glucose or
starch) diets. In our study, the mRNA of PK, FAS, and GPAT were highly
induced when dietary glucose was replaced with fructose (Fig. 3 B, D).
Although ACC and FAS genes are induced by both ChREBP and SREBP-1[24,51,53,54], PK is responsive to only ChREBP [55], suggesting
ChREBP as a possible mediator of the fructose effect on these genes.
Moreover, a recent study with primary cultures of hepatocytes iden-
tiﬁed genes dependent on Mlx, an obligatory dimerization partner of
ChREBP. The Mlx responsive genes included KHK, aldolase B, G6Pase,
FBPase and PFK I [56]. These genes were also induced in our study by
dietary fructose (Fig. 3 A, B, C), further suggesting involvement of
ChREBP in regulation of gene expression by fructose. This suggested
involvement of ChREBP in mediating the fructose effect is further
supported by a report that ChREBP-null mice were intolerant of a
high-fructose diet [26], and our observation that ChREBP mRNA itself
was also responsive to dietary fructose (Fig. 3 F).
Activity of ChREBP is regulated by xylulose 5-phosphate, an inter-
mediate metabolite of the pentose phosphate pathway. When the
pentose phosphate pathway is active, xylulose 5-phosphate increases
and activates a protein phosphatase 2A [57,58], which in turn dephos-
phorylates and activates the ChREBP [59]. The present study showed
that 2 weeks of fructose feeding increased the activity of G6PD, the
regulatory enzyme of the pentose phosphate pathway (Fig. 4). Pa-
gliassotti et al. also reported that sucrose feeding produced a four-fold
347H.-Y. Koo et al. / Biochimica et Biophysica Acta 1782 (2008) 341–348increase in xylulose 5-phosphate in liver [13]. Taken together, induc-
tion of genes by dietary fructose observed in our study is likely to be
mediated at least in part by ChREBP although changes in hormonal
milieu (Table 3) may also have a role.
Although mRNA processing is likely the major regulatory step of
G6PD activity [60], no correlation was observed between the mRNA
and the activity of G6PD in this study (Fig. 3). Thus, the mechanism by
which fructose increases G6PD activity is yet to be elucidated.
4.3. Changes in fasting lipid metabolism in the fructose group
Differences in gene expression and metabolic outcome between the
glucose and fructose groups becamemuch less in a fasted state than in a
fed state (Fig. 5 A, B). Nevertheless, lipid metabolism showed a clear
difference between the two dietary treatments (Fig. 5 B). In the fasted
state, the fructose group showed signiﬁcantly lower NEFA, triglycerides
(Table 2) andMTPmRNA (Fig. 3D) in liver than the glucose group.MTP is
rate-limiting for VLDL secretion [61], and its activity is mainly regulated
at transcription [32,62]. Thus, decreased substrates (NEFA and triglycer-
ides) and MTP mRNA suggest a reduction in VLDL synthesis in the
fructose group when the animals were fasted. In contrast, plasma VLDL
triglycerides in the fructose groupwere higher in the fasted state than in
the glucosegroup (Table 3). Thus, ourdata suggest that elevatedVLDLTG
in the fasted fructose groupmaybedue todecreasedVLDL clearance, not
increased secretion. Consistent with this observation, Hirano et al.
reported a slow VLDL catabolism in fructose-fed rats [63]. Because
hepatic glycogen stores were highly increased by fructose feeding, the
extrahepatic tissues in the fructose group may draw more energy from
plasma glucose and less from VLDL TG during fasting, resulting in slow
VLDL clearance. Determining VLDL turnover and respiratory quotient
will be required to test this hypothesis.
5. Conclusions
In conclusion, we have shown in this study that 1) dietary fructose
induced a broader range of genes in a fed state than previously
identiﬁed including induction of KHK, aldolase B, FBPase, PFK I and
ChREBP, but not PEPCK, 2) G6PD activity was higher in the fructose
group than in the glucose group in both fed and fasted states, sug-
gesting activation of ChREBP, 3) genes induced by dietary fructose
overlap with genes induced by ChREBP/Mlx, suggesting ChREBP as a
likely mediator of gene induction by fructose, 4) fructose was robustly
converted to glucose and stored as glycogen in liver without dietary
glucose, and 5) high dietary fructose resulted in low liver triglycerides
and MTP with high plasma VLDL triglycerides in the fasted fructose
group, suggesting a possible shift of energy source of extra hepatic
tissues from triglycerides to glucose. Underlying mechanisms of these
fructose effects are yet to be elucidated.
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